Jenburkt Pharmaceuticals Limited (BOM:524731)
India · Delayed Price · Currency is INR 1,341.30
-26.40 (-1.93%)
At close: Jul 11, 2025
Jenburkt Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 320.61 | 259.77 | 246.07 | 222.97 | 165.02 | Upgrade |
Depreciation & Amortization | 25.2 | 20.63 | 21.28 | 17 | 16.63 | Upgrade |
Other Amortization | 2.08 | 2.77 | 1.31 | 1.98 | 3.73 | Upgrade |
Loss (Gain) From Sale of Assets | 0.34 | 0.19 | 0.49 | -0.33 | -0.02 | Upgrade |
Loss (Gain) From Sale of Investments | -8.58 | -1.33 | -0.04 | -0.02 | -0.01 | Upgrade |
Provision & Write-off of Bad Debts | 0.79 | 12.88 | 5.93 | 0.84 | 1.92 | Upgrade |
Other Operating Activities | -66.32 | -31.5 | -44.02 | -41.82 | -45.23 | Upgrade |
Change in Accounts Receivable | -11.45 | -36.86 | -15.87 | -10.45 | 36.37 | Upgrade |
Change in Inventory | -3.19 | -2.24 | 15.5 | -23.06 | 33.17 | Upgrade |
Change in Accounts Payable | 18.98 | 1.6 | -10.14 | 25.18 | -16.14 | Upgrade |
Change in Other Net Operating Assets | 0.6 | -144.68 | -49.99 | -99.57 | -0.89 | Upgrade |
Operating Cash Flow | 279.06 | 81.24 | 170.52 | 92.71 | 194.55 | Upgrade |
Operating Cash Flow Growth | 243.51% | -52.36% | 83.92% | -52.34% | 29.55% | Upgrade |
Capital Expenditures | -197.14 | -25.54 | -21.05 | -30.54 | -11.45 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 0 | 5.06 | 0.3 | Upgrade |
Investment in Securities | 1,501 | 1,204 | 31.84 | -37.3 | -214.78 | Upgrade |
Other Investing Activities | -1,474 | -1,184 | 15.38 | 50.75 | 38.12 | Upgrade |
Investing Cash Flow | -170.45 | -5.8 | 26.18 | -12.02 | -187.81 | Upgrade |
Long-Term Debt Repaid | -5.61 | -5.1 | -5.1 | -5.1 | -5.1 | Upgrade |
Net Debt Issued (Repaid) | -5.61 | -5.1 | -5.1 | -5.1 | -5.1 | Upgrade |
Repurchase of Common Stock | - | - | -145.15 | - | - | Upgrade |
Common Dividends Paid | -67.81 | -63.18 | -55 | -46.8 | - | Upgrade |
Other Financing Activities | -2.8 | -2.5 | -5.17 | -3.41 | -2.04 | Upgrade |
Financing Cash Flow | -76.22 | -70.78 | -210.41 | -55.31 | -7.14 | Upgrade |
Net Cash Flow | 32.39 | 4.66 | -13.71 | 25.38 | -0.4 | Upgrade |
Free Cash Flow | 81.92 | 55.7 | 149.48 | 62.17 | 183.1 | Upgrade |
Free Cash Flow Growth | 47.09% | -62.74% | 140.43% | -66.05% | 75.00% | Upgrade |
Free Cash Flow Margin | 5.40% | 3.92% | 10.93% | 5.01% | 16.75% | Upgrade |
Free Cash Flow Per Share | 18.56 | 12.62 | 32.74 | 13.55 | 39.90 | Upgrade |
Cash Interest Paid | 2.8 | 2.5 | 5.16 | 3.41 | 3.48 | Upgrade |
Cash Income Tax Paid | 134.33 | 82.63 | 82.24 | 75.61 | 58.37 | Upgrade |
Levered Free Cash Flow | 87.39 | 182.75 | 131.18 | 143.35 | 166.54 | Upgrade |
Unlevered Free Cash Flow | 89.76 | 184.19 | 133.05 | 145.52 | 169.19 | Upgrade |
Change in Net Working Capital | -24.09 | 6.08 | 44.67 | 1.9 | -48.98 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.